A low‑grade fever saps my ambition and steals the day away from me

Some symptoms arrive with fanfare — a cough that won’t settle, a flare that tightens the chest, a night when the oxygen just doesn’t feel like enough. But others slip in quietly.

Lately, I’ve been having days when my temperature rises just a little above normal. Not a true fever, just a warm hum under the skin. On those days, my ambition disappears. My body feels heavy, my mind slows, and even the simplest tasks feel like they belong to someone stronger than me.

Then I take Tylenol, and within an hour, I feel like myself again. The fog lifts. The day returns. It’s such a small shift, but it has made me pay attention in a new way. Tylenol doesn’t reduce inflammation, but it can lower a mild fever, which may be why it helps.

Recommended Reading

March 4, 2026 News by Marisa Wexler, MS

US study names COPD therapy Anoro Elipta top choice for new patients

‘Warm days’ are harder days

What I’ve learned is that even a mild increase in body temperature can be a sign of systemic inflammation — the body’s quiet alarm. For people living with chronic obstructive pulmonary disease (COPD), inflammation is always part of the landscape. Our airways stay irritated, our lungs stay sensitive, and our immune systems stay on alert. Most days, that background noise is manageable. But some days, the inflammatory load rises just enough to tip the balance, and the whole system slows down to compensate.

Doctors sometimes call these “inflammatory days.” Patients call them “the days when everything feels harder.” On those days, the body diverts energy toward managing inflammation, leaving less for thinking, moving, or doing. It’s not laziness. It’s physiology. And when Tylenol lowers the temperature, my energy returns.

COPD rarely travels alone, and comorbidities can complicate the picture. My history of thyroid disease means my internal thermostat is more sensitive than most. A past run of illnesses — shingles, diverticulitis, and a respiratory infection — left my system more reactive. And like many people with chronic illness, I live with a nervous system that sometimes over-responds to small changes. Any of these can contribute to those “warm days” when my temperature rises just enough to make my whole body feel like it’s moving through molasses.

People often see me on my good days — the days when I’m moving, writing, cooking, or out in the world with my portable oxygen concentrator. They don’t see the days when my body is running warm and slow, when even sitting upright feels like a chore, when the only thing I accomplish is listening to what my body is trying to say.

Chronic illness teaches you to respect the invisible work your body is doing. It teaches you to notice the small changes, the subtle shifts, the quiet alarms. It teaches you that “not wanting to do anything” is sometimes your body’s way of protecting you.

I’m learning not to judge those days. Not to push through them. Not to call myself lazy or unmotivated. Instead, I’m learning to treat them like the fog that settles in the mountains: a sign of moisture in the air, a shift in the weather, a reminder that the landscape is alive and changing. When the fog lifts, I move again. When it doesn’t, I rest.

COPD has taught me many things, but this may be one of the most important: Your ambition isn’t gone. It’s just waiting for the inflammation to settle. And sometimes, the kindest thing you can do is honor the fog until the sun comes back.

Note: COPD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of COPD News Today or its parent company, Bionews, and are intended to spark discussion about issues about chronic obstructive pulmonary disease.